BUSINESS MODEL IV: DIAGNOSTICS  COMPANY

Thursday, July 1, 09:00 - 10:00


Willemijn Vader | CEO

Willemijn Vader is an experienced entrepreneur dedicated to deliver novel solutions to the market that benefit patients and bring (economical) value to the health care system. She has over 15 years in experience in the oncology field. She completed her PhD at the LUMC, and worked 13 years for Sanofi. She is a talented networker with a proven record in commercial effectiveness. Willemijn has generated fast engagement of medical professionals to collaborate in VitroScans development. She has successfully closed a round of investment in 2019, created financing opportunities by formation of grant consortia (Eurostars), and is responsible for establishing the team to effectively manage growth of VitroScan. Willemijn is intrinsically motivated to make a success of innovations that improve the treatment, and quality of life of patients. 


About VitroScan

VitroScan is a Dutch biotech start-up company based at the Leiden Bio Science Park.Treatment decisions for cancer patients become increasingly more complex. VitroScan develops fast and accurate predictive testing for multiple cancers and treatments to support better informed treatment decisions for cancer patients. 

VitroScan was founded in September 2016 with a license to 3D tumor testing technology to develop cancer diagnostics. 

The team consist of experienced and successful entrepreneurs, with extensive networks in fields of clinical oncology, pharma, (bio) information technology. 

Powered by:
BCF Courses BV   

    Connect with us                  

Join BioBusiness Summer School

Privacy Policy
Terms & Conditions 

Chamber of Commerce: 75874415
         
  
  
  
                                    

        REGISTER NOW
    

© Copyright 2020 by BCF Courses